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SET7/9 REPRESSES SIRT1 TO INDUCE COLLAGEN TYPE II EXPRESSION
IN 3D CULTURED HUMAN CHODROCYTES
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Abstract
Objective: Collagen type II (Col-II) plays a signiﬁcant role in skeletal
development and cartilage homeostasis and its loss with age is asso-
ciated with degenerative joint diseases such as osteoarthritis (OA).
Previously ﬁndings establish that the protein deacetylase SirT1 is
required for enhanced expression of Col-IIa1, a major cartilage struc-
tural component of Col-II. Here we proﬁle the mechanism by which
SirT1 activates promoter-driven Col-IIa1 expression.
Methods: Chondrocytes derived from human osteoarthritic knee
joints were encapsulated in three-dimensional alginate hydrogel
microbeads (3D) and compared to paired monolayer (2D, passage 2)
cultures derived from the same donor tissue. 3D-cultured cells
displayed augmented expression of Col-IIa1 and were subject to
serial chromatin immunoprecipitation (ChIP) and ChIP reChIP
analyses to characterize epigenetic variations as compared to 2D
cultures.
Results: ChIP analyses exhibited enrichment for SirT1 and the histone
methyl transferase Set7/9, which formed a complex in 3D cultures
wherein Col-IIa1 was augmented in expression. Consistent with
enriched Set7/9 levels on the Col-IIa1 promoter, ChIP data revealed
enriched levels of trimethylation on histone 3 lysine 4 (3MeH3K4).
Acetylated H3K9/14 and H4K16 on Col-IIa1 promoters of 3D-cultured
chondrocytes were also elevated indicating that SirT1 is enzymatically
repressed by Set7/9 on the transactivated Col-IIa1 promoter. Elevated
marks of the Histone acetyl transferases GCN5 and P300 also supported
the local enrichment of their acetylated histone marks (i.e. H3K9/
14,H4K5 and H4K16).
Conclusions: The data support that Set7/9 is capable of locally
repressing SirT1 enzymatic activity on the promoter of Col-IIa1,
resulting in its augmented expression dependent on cell morphology.325
NEW INSIGHTS INTO THE MOLECULAR BASIS OF THE METABOLIC
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Purpose: Metabolic alterations take place in osteoarthritis (OA).
Thus, the aim of this work is to analyze the gene expression of
glucose and lipid metabolism related genes such as Facilitated
glucose transporter members (GLUT1, GLUT3 and GLUT5), Hexoki-
nase isoforms 1 and 2 (HK1, HK2), Insulin Receptor (INSR), Mito-
chondrial uncoupling protein 2 (UCP2) and Oxidized low density
lipoprotein receptor 1 (OLR-1) in articular cartilage samples from OA
patients and normal (N) controls.
Methods: Total RNA from 12 OA and 8 N cartilage samples was isolated
using RNeasy Kit (Qiagen) following manufacturer's instructions. RNA
was checked for integrity and purity by means of both NanoDrop
spectrophotometer (Thermo Scientiﬁc) and agilent 2100 bioanalyzer
(Agilent). The cDNA was obtained by reverse transcription using
Superscript VILO cDNA Synthesis kit (Invitrogen), and ampliﬁed by qRT-
PCR with LightCycler 480 II system (Roche). The Hypoxantine phos-
phoribosyltransferase-1 (HPRT1) was used as constitutive gene. Data
analysis was performed with qBase plus software (Biogazelle) and SPSS
software (v19).
Results: We analyzed the expression levels of GLUT1, GLUT3, GLUT5,
HK1, HK2, INSR, UCP2 and OLR-1 in OA and N cartilage samples. The OA/
N expression ratio of GLUT1 (1.42  0.6), GLUT3 (1.26  0.06), GLUT5
(0.7  0.2), HK1 (1.04  0.05), HK2 (1.6  0.21) and INSR (0.99  0.08)did not show signiﬁcant differences in any case (p > 0.05). However, OA
cartilage samples showed a signiﬁcantly increased expression ratio for
UCP2 (3.86  0.12) (p< 0.05); moreover, in the case of normal cartilage,
a positive correlation between the expression of UCP2 and GLUT3 was
also detected (Pearson correlation coefﬁcient 0.917, p <0.05), whereas
this correlation is lost in the case of OA. Only OA cartilage samples
expressed OLR-1, and even signiﬁcant differences in gene expression
between two subgroups of OA samples were detected (fold change ¼
38.6; p<0.0001).
Conclusions: Overexpression of UCP2 in OA may be important in
causing tissue damage in addition to its function as uncoupling of the
respiratory chain. The increased OLR-1 expression in a subgroup of OAs
could be a factor relevant to the origin of the OA in certain individuals,
and could support the possible involvement of oxidized low density
lipoprotein (ox-LDL) in the impairment of both the ox-LDL metabolism
and the inﬂammatory process.326
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Osteoarthritis (OA) represents the most common form of arthritis and
has a substantive clinical and economic impact. Our recent studies
have successfully identiﬁed numerous genetic loci associated with OA.
Despite this, a substantial proportion of the causality for OA remains
unexplained. We hypothesize that epigenetic mechanism is an
important factor that accounts for the missing heritability in OA and
we tested our hypothesis using an epigenome-wide association
approach.
Methods and Patients: Human cartilage tissue samples were collected
from six total hip joint replacement patients, two of which had primary
OA and four controls with hip fracture that exhibited no evidence of OA.
DNA was extracted from the cartilage samples using DNeasy Blood and
Tissue kit. Genome-wide DNA methylation proﬁling was performed on
these six cartilage DNA samples plus additional 18 blood DNA samples
from 18 OA patients. The proﬁling was done using Illumina Human-
Methylation450k Beadchip, which measures up w480,000 different
CpG sites per sample, covers 96% of RefSeq genes, and provides
comprehensive gene region coverage, targeting multiple sites with
promoter, 5’ UTR,1st exon, gene body, and 3’ UTR. The methylation level
at each CpG site was measured by b values varying from 0 (no meth-
ylation) to 1 (100% methylation).
Results: A series of QC steps were applied to the initial methylation
data on 485,577 CpG sites. After QC, we had data on 383,136 auto-
somal CpG sites, which were included in the subsequent analysis. We
found that the distributions of the global methylation levels for the
three groups (cartilage DNA for OA, and controls, and blood DNA for
OA patients) are bimodal, which is consistent with previous report.
However, blood samples had a signiﬁcantly higher number of
methylated regions than cartilage samples of both OA cases and
controls. We found that three CpG sites in the MMP3 gene and one
CpG site in MMP13 were demethylated in OA cases compared to
controls (all p <0.05), consistent with previous reports. Two CpG
sites in MMP9 were associated with OA (all p <0.05), but the effect
size was opposite between these two CpG sites. We didn't ﬁnd any
association with ADAMTS4 but found two CpG sites located in the 1st
exon of ADAMTS5 were signiﬁcantly methylated in OA cases (all
p<0.01). We found one CpG site in IL-1b was methylated and one
CpG site in GDF5 was demethylated in OA. Epigenome-wide associ-
ation analysis didn't ﬁnd any signals that reach genome-wide
signiﬁcance level (p<10-7) due to small sample size but found there
are many potential OA genes with methylation changes that haven't
been reported previously.
Conclusion: Our preliminary result demonstrate that global DNA
methylation pattern in human cartilage tissue is different from that in
blood and we conﬁrmed many of previously reported candidate gene
methylation associations with OA. Our study also demonstrated that
epigenome-wide approach is feasible to investigate the epigenetic
factors in OA.
